To further demonstrate that IMPA2 can generate drug resistance by affecting paclitaxel-mediated apoptosis, we selected cervical cancer cells with stable knockdown ofIMPA2 and control cells. This evidence concerns the gene IMPA2 and cervical carcinoma.